FGFR2 and cholangiocarcinoma: Furthermore, TCF7 reinforces CCA progression by positively regulating MYC and FOSL1 (Liu et al, 2019) and induces CCA proliferation and drug resistance, via regulating SOX9/FGF7/FGFR2 axis (Liu et al, 2022b).